Flatiron Health
Roche's Flatiron Health, Foundation Medicine, Genentech Launch Clinico-Genomic Lung Cancer Study
The prospective study will combine real-world, clinical, and genomic data to streamline lung cancer clinical trials and find treatment-response biomarkers.
Researchers are collecting genomic and clinical data on cancer patients outside of clinical trials to understand tumor biology, treatment efficacy, and care gaps.
Keytruda, Vitrakvi Approvals Spur Search for Other Targetable Biomarkers With Pan-Cancer Potential
Premium
The approval of two molecularly targeted, tissue-agnostic therapies, has shown researchers that there is a path forward for other pan-cancer markers.
Tissue-agnostic drug development approaches have their own set of scientific and financial considerations, but some drugmakers are taking on those challenges.
Foundation Medicine, Flatiron Health Publish Clinical Validity of Clinico-Genomics Database
In the JAMA study, researchers confirmed the previously known clinical and genomic features of NSCLC patients in their large clinico-genomics database.